GoodRx Holdings, Inc. (GDRX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $34.00K; Additional Paid in Capital, Common StockUSD $2.05B; Retained Earnings (Accumulated Deficit)USD $-1.40B.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $34.00K; Additional Paid in Capital, Common StockUSD $2.03B; Retained Earnings (Accumulated Deficit)USD $-1.41B.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $34.00K; Additional Paid in Capital, Common StockUSD $2.03B; Retained Earnings (Accumulated Deficit)USD $-1.41B.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $34.00K; Additional Paid in Capital, Common StockUSD $2.02B; Retained Earnings (Accumulated Deficit)USD $-1.42B.
GoodRx Holdings, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $34.00K | $2.05B | $-1.40B | $647.60M | 3 month · $19.84M |
| 2026-03-31 | $0.00 | $34.00K | $2.03B | $-1.41B | $621.99M | 3 month · $19.68M |
| 2025-12-31 | $0.00 | $34.00K | $2.03B | $-1.41B | $616.26M | 12 month · $91.70M |
| 2025-09-30 | $0.00 | $34.00K | $2.02B | $-1.42B | $600.71M | 3 month · $21.66M |
| 2025-06-30 | $0.00 | $35.00K | $2.06B | $-1.42B | $643.03M | 3 month · $25.88M |
| 2025-03-31 | $0.00 | $36.00K | $2.08B | $-1.43B | $654.35M | 3 month · $23.31M |
| 2024-12-31 | $0.00 | $38.00K | $2.17B | $-1.44B | $724.66M | 12 month · $115.15M |
| 2024-09-30 | $0.00 | $38.00K | $2.14B | $-1.45B | $696.43M | 3 month · $30.60M |
| 2024-06-30 | $0.00 | $38.00K | $2.12B | $-1.45B | $669.40M | 3 month · $30.89M |
| 2024-03-31 | $0.00 | $38.00K | $2.09B | $-1.46B | $631.07M | 3 month · $28.89M |
| 2023-12-31 | $0.00 | $40.00K | $2.22B | $-1.46B | $761.96M | 12 month · $117.96M |
| 2023-09-30 | $0.00 | $40.00K | $2.31B | $-1.43B | $881.27M | 3 month · $36.35M |
| 2023-06-30 | $0.00 | $40.00K | $2.29B | $-1.39B | $895.37M | 3 month · $21.35M |
| 2023-03-31 | $0.00 | $40.00K | $2.28B | $-1.45B | $827.47M | 3 month · $28.26M |
| 2022-12-31 | $0.00 | $40.00K | $2.26B | $-1.45B | $814.83M | 12 month · $129.20M |
| 2022-09-30 | $0.00 | $40.00K | $2.23B | $-1.45B | $788.40M | 3 month · $32.15M |
| 2022-06-30 | $0.00 | $40.00K | $2.22B | $-1.40B | $817.94M | 3 month · $33.47M |
| 2022-03-31 | $0.00 | $40.00K | $2.19B | $-1.40B | $786.51M | 3 month · $32.16M |
| 2021-12-31 | $0.00 | $40.00K | $2.25B | $-1.42B | $831.68M | 12 month · $168.17M |
| 2021-09-30 | $0.00 | $39.00K | $2.22B | $-1.38B | $846.40M | 3 month · $42.59M |
| 2021-06-30 | (m) | $39.00K | $2.18B | $-1.36B | $824.39M | 3 month · $42.37M |
| 2021-03-31 | (m) | $39.00K | $2.14B | $-1.39B | $749.06M | 3 month · $48.25M |
| 2020-12-31 | $0.00 | $39.00K | $2.10B | $-1.39B | $711.36M | 12 month · $399.72M |
| 2020-09-30 | (m) | (m) | $1.85B | $-1.09B | $756.41M | 3 month · $107.83M |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-1.03B | 3 month · $2.44M |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-1.06B | 3 month · $2.50M |
| 2019-12-31 | (m) | (m) | $8.79M | $-1.10B | $-1.09B | 12 month · $4.13M |
| 2019-09-30 | (m) | (m) | (m) | (m) | $-1.10B | 3 month · $1.07M |
| 2019-06-30 | (m) | (m) | (m) | (m) | $-1.13B | 3 month · $1.06M |
| 2019-03-31 | (m) | (m) | (m) | (m) | $-1.15B | 3 month · $887.00K |
| 2018-12-31 | (m) | (m) | (m) | (m) | $-1.16B | 12 month · $1.76M |
| 2017-12-31 | (m) | (m) | (m) | (m) | $-31.75M | (m) |